March 11 (Reuters) - Alligator Bioscience AB ATORX.ST :
* MITAZALIMAB SYNERGIZES WITH CHEMOTHERAPY - ALLIGATOR
BIOSCIENCE
PRESENTS NEW PRECLINICAL DATA AT AACR
* NEW PRECLINICAL DATA ARE VERY ENCOURAGING
* TOGETHER WITH CLINICAL DATA OF MITAZALIMAB FROM A PREVIOUS
PHASE
I STUDY DATA SUPPORT UPCOMING CLINICAL PHASE II STUDY OF
MITAZALIMAB IN COMBINATION WITH CHEMOTHERAPY IN PANCREATIC
CANCER PATIENTS
Source text for Eikon: ID:nWkr6ns3JS
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))